Exact Mass: 308.1767
Exact Mass Matches: 308.1767
Found 500 metabolites which its exact mass value is equals to given mass value 308.1767
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
bestatin
KEIO_ID B018; [MS2] KO009090 KEIO_ID B018 Bestatin is a natural, broad-spectrum, and competitive CD13 (Aminopeptidase N)/APN and leukotriene A4 hydrolase inhibitor. Bestatin has anticancer effects[1][2].
Inulicin
Britannilactone 1-O-acetate is a natural product found in Pentanema britannicum and Inula japonica with data available. Inulicin (1-O-Acetylbritannilactone) is an active compound that inhibits VEGF-mediated activation of Src and FAK. Inulicin (1-O-Acetylbritannilactone) inhibits LPS-induced PGE2 production and COX-2 expression, and NF-κB activation and translocation. Inulicin (1-O-Acetylbritannilactone) is an active compound that inhibits VEGF-mediated activation of Src and FAK. Inulicin (1-O-Acetylbritannilactone) inhibits LPS-induced PGE2 production and COX-2 expression, and NF-κB activation and translocation.
Tetraphyllicine
2-(3,7-Dimethyl-2,6-octadienyl)-3-methyl-1,4-naphthoquinone
2-[(2E)-3,7-dimethylocta-2,6-dienyl]-5-methylnaphthalene-1,4-dione
(R)-1-O-b-D-glucopyranosyl-1,3-octanediol
(R)-1-O-b-D-glucopyranosyl-1,3-octanediol is found in pomes. (R)-1-O-b-D-glucopyranosyl-1,3-octanediol is a constituent of apples Constituent of apples. (R)-1-O-b-D-glucopyranosyl-1,3-octanediol is found in pomes.
15-Deacetylcalonectrin
15-Deacetylcalonectrin is a metabolite of Calonectria nivali
ACRL Toxin II
ACRL Toxin II is found in citrus. ACRL Toxin II is produced by the fungus Alternaria citri on rough lemo Production by the fungus Alternaria citri on rough lemon. ACRL Toxin II is found in citrus.
Dihydrocumambrin A
Dihydrocumambrin A is found in garland chrysanthemum. Dihydrocumambrin A is from Chrysanthemum coronarium (chop-suey greens). From Chrysanthemum coronarium (chop-suey greens). Dihydrocumambrin A is found in garland chrysanthemum and herbs and spices.
Gestrinone
Gestrinone was developed in the early 1970s and was tested clinically as a weekly oral contraceptive in European and North American countries. ]. Without significant advantages over other oral contraceptives and with its high price, gestrinone was no longer used after the Stage II clinical trial. However, from 1982 aroused widespread interest due to substantial therapeutic effects in treating endometriosis. Under different endocrine conditions, gestrinone possesses estrogenic, progestational, androgenic, antiestrogenic and antiprogesterone actions. Starting from gestrinone, chemists can synthesize tetrahydrogestrinone (THG) in one reaction step. THG is a real designer steroid; designer steroids (chemically modified steroids) pose a threat to the integrity of the sport community. These compounds have recently been detected in urine specimens from athletes, resulting in temporary or permanent suspension from amateur and/or professional competition. (PMID: 15934041, 17707720) [HMDB] Gestrinone was developed in the early 1970s and was tested clinically as a weekly oral contraceptive in European and North American countries. ]. Without significant advantages over other oral contraceptives and with its high price, gestrinone was no longer used after the Stage II clinical trial. However, from 1982 aroused widespread interest due to substantial therapeutic effects in treating endometriosis. Under different endocrine conditions, gestrinone possesses estrogenic, progestational, androgenic, antiestrogenic and antiprogesterone actions. Starting from gestrinone, chemists can synthesize tetrahydrogestrinone (THG) in one reaction step. THG is a real designer steroid; designer steroids (chemically modified steroids) pose a threat to the integrity of the sport community. These compounds have recently been detected in urine specimens from athletes, resulting in temporary or permanent suspension from amateur and/or professional competition. (PMID: 15934041, 17707720). G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03X - Other sex hormones and modulators of the genital system > G03XA - Antigonadotropins and similar agents D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D011372 - Progestins C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents
Indecainide
Indecainide is only found in individuals that have used or taken this drug. It is a rarely used antidysrhythmic. Indecainide has local anesthetic activity and belongs to the membrane stabilizing (Class 1) group of antiarrhythmic agents; it has electrophysiologic effects characteristic of the IC class of antiarrhythmics.Indecainide acts on sodium channels on the neuronal cell membrane, limiting the spread of seizure activity and reducing seizure propagation. The antiarrhythmic actions are mediated through effects on sodium channels in Purkinje fibers. C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent
8-Hydroxycarteolol
8-Hydroxycarteolol is a metabolite of carteolol. Carteolol (trade names Cartrol, Ocupress, Teoptic, Arteolol, Arteoptic, Calte, Cartéabak, Carteol, Cartéol, Cartrol, Elebloc, Endak, Glauteolol, Mikelan, Poenglaucol, Singlauc) is a non-selective beta blocker used to treat glaucoma. (Wikipedia)
(2R)-2-[[(2S,3R)-3-Amino-2-hydroxy-4-phenyl-butanoyl]amino]-4-methyl-pentanoic acid
1-O-Acetyl britannilactone
Inulicin (1-O-Acetylbritannilactone) is an active compound that inhibits VEGF-mediated activation of Src and FAK. Inulicin (1-O-Acetylbritannilactone) inhibits LPS-induced PGE2 production and COX-2 expression, and NF-κB activation and translocation. Inulicin (1-O-Acetylbritannilactone) is an active compound that inhibits VEGF-mediated activation of Src and FAK. Inulicin (1-O-Acetylbritannilactone) inhibits LPS-induced PGE2 production and COX-2 expression, and NF-κB activation and translocation.
Baquiloprim
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
Ubenimex
Ubenimex (also known as bestatin) is a competitive protease inhibitor. It is an inhibitor of aminopeptidase B, leukotriene A4 hydrolase, aminopeptidase N. It is being studied for use in the treatment of acute myelocytic leukemia. Ubenimex is a microbial metabolite and dipeptide with potential immunomodulatory and antitumor activities. Ubenimex competitively inhibits many aminopeptidases, including B, N and leucine aminopeptidases. Aminopeptidases has been implicated in the process of cell adhesion and invasion of tumor cells. Therefore, inhibiting aminopeptidases may partially attribute to the antitumor effect of ubenimex. This agent also activates T lymphocyte, macrophage and bone marrow stem cell as well as stimulates release of interleukin-1 and -2, thus further enhances its antitumor activity. D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C308 - Immunotherapeutic Agent > C2139 - Immunostimulant D000970 - Antineoplastic Agents D007155 - Immunologic Factors Bestatin is a natural, broad-spectrum, and competitive CD13 (Aminopeptidase N)/APN and leukotriene A4 hydrolase inhibitor. Bestatin has anticancer effects[1][2].
Dihydro-beta-cyclopyrethrosin
4beta-Acetoxy-6alpha-hydroxy-11(13)-pseudoguaien-12,8alpha-olide
6alpha-Acetoxy-4beta-hydroxy-11(13)-pseudoguaien-12,8alpha-olide
Diacetolol
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist
Baquiloprim
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent CONFIDENCE standard compound; INTERNAL_ID 1178
1-Acetylerivanin|1alpha-acetoxy-3alpha-hydroxy-5,7alpha,6,11beta(H)-eudesm-4,15-en-6,12-olide
1alpha-acetoxy-4alpha-hydroxy-5,7alpha,6,11beta(H)-eudesm-2,3-en-6,12-olide|1alpha-Acetoxy-4alpha-hydroxy-5alpha,6beta,7alpha,11beta-H-eudesm-2-en-12,6-olide
8-Ac-(1beta,6alpha,8beta,11alphaH)-1,8-Dihydroxy-3-eudesmen-12,6-olide
1-(2,2-dimethyl-3-hydroxypropyl)-2-isobutyl phthalate
1alpha-acetoxy-5beta-hydroxyeudesm-3-en-6beta,11betaH-12,6-olide
3-(1-methyl-piperidin-2-yl)-3,4-dihydro-2H-benzo[c]pyrido[1,2-a]azepin-6-one
3,4,5-Tri-Me ether,O-(3-methylbutanoyl)-3-(3,4,5-Trihydroxyphenyl)-2-propen-1-ol|3,4,5-trimethoxycinnamyl isovalerate
8beta-Acetoxy-3beta-hydroxy-11alpha,13-dihydrocostunolid
8-Hydroxy-3,8a-dimethyl-5-methylene-2-oxododecahydronaphtho[2,3-b]furan-4-yl acetate #
(4S,4aR,5S,8aR,9aS)-4-(acetyloxy)-4a,5,6,7,8,8a,9,9a-octahydro-9a-hydroxy-3,4a,5-trimethylnaphtho[2,3-b]furan-2(4H)-one|(6beta,8alpha)-6-(acetyloxy)-8-hydroxyeremophil-7(11)-en-12,8-olide
4-Ac-4,5-Seconeopulchell-5-ene|4-O-acetyl-4,5-seco-neopulchell-5-ene
4-acetoxy-1beta,5beta-epoxy-10alphaH-xantha-11(13)-en-12,8beta-olide|4-Acetoxy-1??,5??-epoxy-10??H-xantha-11(13)-en-12,8??-olide
(+/-)-nitraraine|(-)-nitraraine|Alloyohimb-16-en-16-methanol|Nitraraine|yohimb-16-en-16-yl-methanol
1beta,6alpha,8beta-Trihydroxy-11,13-dihydroeudesm-4-en-6-olide 8-acetate
9beta-acetoxy-15-hydroxyeudesm-4,11(13)-dien-12-oic acid
2,2-Dimethyl-5,6,8-trimethoxy-7-(1-methoxyethyl)-2H-1-benzopyran
3alpha-acetoxy-11alphaH,13-dihydrodamsin|hydroxydihydrodamsin
N(1)-methyl-14,15-didehydro-12-hydroxyaspidofractinine
Ac-(1alpha,3beta,4Z,8beta,10beta,11alpha)-1,10-Epoxy-3-hydroxy-4-germacren-12,8-olide
2alpha-acetoxy-5alpha-hydroxy-11alphaH-eudesma-4(15)-en-12,8beta-olide
4beta,5beta-epoxy-9beta-acetoxyeudesm-11(13)-en-12-oic acid
(1R*,4R*,5R*)-5-hydroxy-4-[(E)-7-hydroxy-4-methylhept-3-enyl]-4,8-dimethyl-3-oxabicyclo[3.3.0]octan-7-en-2,6-dione|gomadalactone B
(3R),(4S)-4-hydroxylasiodiplodin|(3R,4S)-4-hydoxylasiodiplodin
1beta-acetoxy-7-drimen-11alpha-ol-12,11-lactone|1??-Acetoxy-7-drimen-11??-ol-12,11-lactone
(1S,4S,5S,6S,7S,10R)-1-hydroxy-15-acetoxyeudesm-11(13)-en-6,12-olide
1alpha-acetoxy-3beta-hydroxyeudesm-4-en-6beta,11betaH-12,6-olide
6alpha-acetoxy-1-hydroxy-4alphaH-1,10-secoeudesma-5(10),11(13)-dien-12,8beta-olide
11alpha,13-dihydro-2-O-acetylflorilenalin|11alphaH,13dihydroflorilenalin acetate|2alpha-acetoxy-4alpha-hydroxy-1beta,5alpha,11alphaH-guai-10(14)-en-12,8beta-olide
2-Ac-4,5-Seconeopulchell-5-ene|4,5-seco-neopulchell-5-ene-2-O-acetate
(1S,2R,5R,6S,7S,8S,10R)-6-hydroxy-2-ethoxy-4-oxopseudoguai-11(13)-en-12,8-olide
A pseudoguaianolide with anti-inflammatory activity isolated from the aerial parts of Inula hupehensis.
15-hydroxyajanolide A|3beta-acetoxy-15-hydroxygermacra-1(10)E,4Z-dien-6beta,7alpha,11alphaH-12,6-olide|zawadskinolide B
3beta-acetoxy-5alpha-angeloyloxy-7-deoxycarvotacetone|vernonione
2beta-acetoxy-4alpha-hydroxy-11beta,13-dihydroburkeolide
9-Ac-(5alpha,9??)-5,9-Dihydroxy-4(15),11(13)-eudesmadien-12-oic acid|9beta-Acetoxy-5alpha-hydroxycostic Acid
7,8-seco-2,3,5-trihydroxy-12-acetoxycalam-8-ene|myrracalamene B
10betaH,11alphaH-7alpha-acetoxy-8-oxoeremophilan-12,6beta-olide|7-O-acetylsubspicatolide
11-hydroxy-1beta-methoxy-8-oxoeremophila-6,9-dien-12-oic acid methyl ester
4-Ac-4, 10-Dihydroxy-11(13)-guaien-12, 8-olide|4alpha-acetoxy-10beta-hydroxy-1beta(H),5alpha(H)-guai-11(13)-en-8alpha,12-olide
(+)-(4aS,12bS)-4,4,12b-trimethyl-1,2,3,4,4a,5,6,12b-octahydrobenzo[a]anthracene-8,11-dione|(+)-cyclozonarone|Cyclozonarone
1alpha-hydroxy-4beta-O-acetylpseudoguaian-6beta,12-olide
2,4-Dihydroxy-3,6-dimethoxy-5-(3,3-dimethylallyl)-butyrophenon
(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(3-hydroxy-6-methylheptoxy)oxane-3,4,5-triol
(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(3-hydroxy-6-methylheptoxy)oxane-3,4,5-triol [IIN-based on: CCMSLIB00000845933]
(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(3-hydroxy-6-methylheptoxy)oxane-3,4,5-triol [IIN-based: Match]
8-(3-Methoxy-2-(methoxycarbonyl)phenyl)octanoic acid
2-Pyrrolidinone, 4-(2-aminoethyl)-1-ethyl-3,3-diphenyl- (AHR 5904)
Gestrinone
G - Genito urinary system and sex hormones > G03 - Sex hormones and modulators of the genital system > G03X - Other sex hormones and modulators of the genital system > G03XA - Antigonadotropins and similar agents D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D011372 - Progestins C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents
Indecainide
C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent
(R)-1-O-b-D-glucopyranosyl-1,3-octanediol
15-Decalonectrin
Dihydrocumambrin A
15-Acetoxyscirpenol
Mycotoxin from Fusarium roseum and Fusarium sulphureum
(E)-2-(4-METHOXY-3-(3-METHOXYPROPOXY)BENZYLIDENE)-3-METHYLBUTANOIC ACID
4-Boc-7,8-Dimethoxy-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine
2-Methoxycarbonyl-1-phenylethylboronic acid pinacol ester
1-BOC-2-[(4-FLUORO-PHENYLAMINO)-METHYL]-PIPERIDINE
1-BOC-3-[(2-FLUORO-PHENYLAMINO)-METHYL]-PIPERIDINE
1-BOC-3-[(3-FLUOROBENZYL-AMINO)-METHYL]-PYRROLIDINE
1-BOC-3-[(3-FLUORO-PHENYLAMINO)-METHYL]-PIPERIDINE
1-BOC-3-[(4-FLUOROBENZYL-AMINO)-METHYL]-PYRROLIDINE
1-BOC-3-[(4-FLUORO-PHENYLAMINO)-METHYL]-PIPERIDINE
2′-(Di-tert-butylphosphino)acetophenone ethylene ketal
tert-butyl 4-(aminomethyl)-4-(4-fluorophenyl)piperidine-1-carboxylate
1H-Pyrrolo[2,3-b]pyridin-5-ol, 4-fluoro-1-[tris(1-methylethyl)silyl]-
Octyl thioglucoside
D013501 - Surface-Active Agents > D003902 - Detergents
2-(9H-CARBAZOLYL)ETHYLBORONIC ACID DIETHANOLAMINE ESTER
1-BENZYL-4,5-DIHYDRO-3H-SPIRO[BENZO[B][1,4]OXAZEPINE-2,4-PIPERIDINE]
methyl 3,3-dimethoxy-2-oxa-7,10-diaza-3-silatridecan-13-oate
tert-butyl N-[1-(benzylamino)-3-methoxy-1-oxopropan-2-yl]carbamate
1-BOC-3-[(2-FLUOROBENZYL-AMINO)-METHYL]-PYRROLIDINE
(S)-ETHYL 3-(4-AMINOPHENYL)-2-((TERT-BUTOXYCARBONYL)AMINO)PROPANOATE
Benzeneacetic acid,2-[2-(dipropylamino)ethyl]-6-nitro-
(R)-tert-Butyl 1-(benzylamino)-3-methoxy-1-oxopropan-2-ylcarbamate
1-BOC-2-[(2-FLUORO-PHENYLAMINO)-METHYL]-PIPERIDINE
1-BOC-2-[(3-FLUORO-PHENYLAMINO)-METHYL]-PIPERIDINE
3-Fluoro-2-(4-morpholino)pyridine-4-boronic acid pinacol ester
TERT-BUTYL 2-(1-(4-(ETHOXYCARBONYL)PHENYL)ETHYL)HYDRAZINECARBOXYLATE
tert-Butyl 4-(benzylamino)-3-fluoropiperidine-1-carboxylate
Derenofylline
C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator Derenofylline (SLV 320) is a potent, selective and orally active adenosine A1 receptor antagonist, with Ki values of 1 nM, 200 nM and 398 nM for human A1, A3 and A2A receptors respectively. Derenofylline suppresses cardiac fibrosis and attenuates albuminuria without affecting blood pressure in rats[1].
Dimethisoquin hydrochloride
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent
33627-41-7
Inulicin (1-O-Acetylbritannilactone) is an active compound that inhibits VEGF-mediated activation of Src and FAK. Inulicin (1-O-Acetylbritannilactone) inhibits LPS-induced PGE2 production and COX-2 expression, and NF-κB activation and translocation. Inulicin (1-O-Acetylbritannilactone) is an active compound that inhibits VEGF-mediated activation of Src and FAK. Inulicin (1-O-Acetylbritannilactone) inhibits LPS-induced PGE2 production and COX-2 expression, and NF-κB activation and translocation.
Furan-2-ylmethyl-(2-piperidin-1-yl-quinazolin-4-yl)-amine
[(1R,2R,10R)-2-(hydroxymethyl)-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2-oxirane]-10-yl] acetate
2-[(3-Azaniumyl-2-hydroxy-4-phenylbutanoyl)amino]-4-methylpentanoate
[3-Carboxy-2-(4-phenylbutanoyloxy)propyl]-trimethylazanium
2-[2-(3-Ethylphenoxy)ethyl]propanedioic acid diethyl ester
1-[(3-chlorophenyl)methyl]-N,N-diethyl-3-piperidinecarboxamide
1-O-acetyl-4R,6S-britannilactone
A sesquiterpene lactone that is (3aS,4R,7aR)-3a,4,7,7a-tetrahydro-1-benzofuran-2(3H)-one with a methylidene at position C-3, a hydroxy at C-4, a methyl at C-6, and a (2S)-5-(acetyloxy)pentan-2-yl group at position C-5. A natural product found in Inula britannica var chinensis and Inula japonica.
N-[(2R,3R,6S)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide
N-[(2R,3S,6S)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide
N-[(2S,3S,6S)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide
N-[(2S,3R,6R)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide
N-[(2S,3R,6S)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide
N-[(2R,3R,6R)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide
N-[(2R,3S,6R)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide
N-[(2S,3S,6R)-6-[2-(cyclobutylamino)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]cyclopropanecarboxamide
(8S,13S,14R,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
13-Ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
2-[4-(2-Trimethylsilyloxy-2-methylpropyl)phenyl]propanoic acid methyl ester
(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(3-hydroxy-6-methylheptoxy)oxane-3,4,5-triol
(2R)-2-[[(2S,3R)-3-Amino-2-hydroxy-4-phenyl-butanoyl]amino]-4-methyl-pentanoic acid
Bestatin is a natural, broad-spectrum, and competitive CD13 (Aminopeptidase N)/APN and leukotriene A4 hydrolase inhibitor. Bestatin has anticancer effects[1][2].
(1R,9R,10S,12R,13E,16S,18R)-13-ethylidene-8-methyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-trien-18-ol
3-[(3aS,4R,5R,8aR)-4-hydroxy-5,7-dimethyl-3-methylidene-2-oxo-4,5,8,8a-tetrahydro-3aH-cyclohepta[b]furan-6-yl]propyl acetate
Inulicin (1-O-Acetylbritannilactone) is an active compound that inhibits VEGF-mediated activation of Src and FAK. Inulicin (1-O-Acetylbritannilactone) inhibits LPS-induced PGE2 production and COX-2 expression, and NF-κB activation and translocation. Inulicin (1-O-Acetylbritannilactone) is an active compound that inhibits VEGF-mediated activation of Src and FAK. Inulicin (1-O-Acetylbritannilactone) inhibits LPS-induced PGE2 production and COX-2 expression, and NF-κB activation and translocation.
[(2S,3R)-3-Amino-2-hydroxy-4-phenylbutyryl]-L-leucine
(3r,3ar,4s,9r,11ar)-9-hydroxy-3,6,10-trimethyl-2-oxo-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-4-yl acetate
(1s,14r,19r)-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]henicosa-2(10),4,6,8,17-pentaen-17-ylmethanol
(1r,12s,15s,17s)-1,14,14-trimethyl-3,13-diazapentacyclo[13.2.2.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]nonadeca-2(10),4,6,8-tetraen-11-one
(2s,4s)-4-[(3ar,7s,8as)-7-methyl-3-methylidene-2-oxo-3ah,4h,7h,8h,8ah-cyclohepta[b]furan-6-yl]-4-hydroxybutan-2-yl acetate
1-[2,4-dihydroxy-3,6-dimethoxy-5-(3-methylbut-2-en-1-yl)phenyl]butan-1-one
(3s)-7,12-dihydroxy-14-methoxy-3-methyl-3,4,5,6,7,8,9,10-octahydro-2-benzoxacyclododecin-1-one
(3s,3ar,5ar,6s,7s,9as,9bs)-6-hydroxy-3,5a-dimethyl-9-methylidene-2-oxo-octahydro-3h-naphtho[1,2-b]furan-7-yl acetate
(3s,5s)-5,12-dihydroxy-14-methoxy-3-methyl-3,4,5,6,7,8,9,10-octahydro-2-benzoxacyclododecin-1-one
(1r,5as,9r,9as,9br)-1-hydroxy-6,6,9a-trimethyl-3-oxo-1h,5h,5ah,7h,8h,9h,9bh-naphtho[1,2-c]furan-9-yl acetate
(4as,12bs)-4,4,12b-trimethyl-1,2,3,4a,5,6-hexahydrotetraphene-8,11-dione
(2s,3r,12br)-3-ethenyl-2-[(1e)-2-methoxyethenyl]-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine
[(3s,3as,6s,6as,9as,9br)-3,6-dimethyl-2,9-dioxo-octahydro-3h-azuleno[4,5-b]furan-9a-yl]methyl acetate
(9s,10s,11ar)-9-hydroxy-3,6,10-trimethyl-2-oxo-4h,5h,8h,9h,11h,11ah-cyclodeca[b]furan-10-yl acetate
3-ethenyl-2-(2-methoxyethenyl)-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine
{9-hydroxy-6-methyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[4,5-b]furan-9a-yl}methyl acetate
4-hydroxy-3,6,10-trimethyl-2-oxo-3h,3ah,4h,7h,8h,11h,11ah-cyclodeca[b]furan-7-yl acetate
6-[(3r,4e,6s,7s,8e)-3,7-dihydroxy-6,8-dimethyldeca-4,8-dien-2-yl]-4-hydroxypyran-2-one
(3as,6s,6as,9s,9as,9br)-6-(hydroxymethyl)-9a-methyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[4,5-b]furan-9-yl acetate
2-[(1s,2r,5s)-2-(acetyloxy)-5-methyl-4-(3-oxobutyl)cyclohept-3-en-1-yl]prop-2-enoic acid
(3s,3ar,4s,6r,6ar,9ar,9bs)-6-hydroxy-3,6,9-trimethyl-2-oxo-3h,3ah,4h,5h,6ah,7h,9ah,9bh-azuleno[4,5-b]furan-4-yl acetate
(3r,5r)-5,12-dihydroxy-14-methoxy-3-methyl-3,4,5,6,7,8,9,10-octahydro-2-benzoxacyclododecin-1-one
(4ar,5s,8r,8as,9ar)-9a-hydroxy-3,4a,5-trimethyl-2-oxo-4h,5h,6h,7h,8h,8ah,9h-naphtho[2,3-b]furan-8-yl acetate
6-[(2r,3s,4e,6s,7r,8e)-3,7-dihydroxy-6,8-dimethyldeca-4,8-dien-2-yl]-4-hydroxypyran-2-one
{2-[2-(tert-butoxy)-5-methoxy-4-methylphenyl]oxiran-2-yl}methyl acetate
4,4,12b-trimethyl-1,2,3,4a,5,6-hexahydrotetraphene-8,11-dione
[2-(hydroxymethyl)-3-methoxy-4-methyl-5-[(3-methylbut-2-en-1-yl)oxy]phenyl]methyl acetate
8-hydroxy-5,5,8-trimethyl-10-oxo-11-oxatetracyclo[7.3.1.0¹,⁹.0³,⁷]tridecan-2-yl acetate
[(3as,6s,6as,9s,9ar,9br)-9-hydroxy-6-methyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[4,5-b]furan-9a-yl]methyl acetate
4-{7-hydroxy-7-methyl-3-methylidene-2-oxo-3ah,4h,8h,8ah-cyclohepta[b]furan-6-yl}butan-2-yl acetate
(3r,3as,4r,7s,11as)-4-hydroxy-3,6,10-trimethyl-2-oxo-3h,3ah,4h,7h,8h,11h,11ah-cyclodeca[b]furan-7-yl acetate
(1r,4r,7r,8s,12s)-1-hydroxy-7-(2-hydroxypropan-2-yl)-4-methyl-3,13-dioxatetracyclo[10.2.1.0²,¹⁰.0⁴,⁸]pentadec-2(10)-en-11-one
(2r,3r,4s,5s,6r)-2-{[(3r)-3-ethyl-4-hydroxy-4-methylpentyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(1r,3s)-1-[(3as,7s,8as)-7-methyl-3-methylidene-2-oxo-3ah,4h,7h,8h,8ah-cyclohepta[b]furan-6-yl]-3-hydroxybutyl acetate
(1s)-1-[(3s,3ar,7s,8ar)-3,7-dimethyl-2-oxo-3h,3ah,4h,7h,8h,8ah-cyclohepta[b]furan-6-yl]-3-oxobutyl acetate
(3s,3ar,4as,7s,7as,8s,9ar)-3,4a,8-trimethyl-2,5-dioxo-octahydro-3h-azuleno[6,5-b]furan-7-yl acetate
3,4a,8-trimethyl-2,5-dioxo-octahydro-3h-azuleno[6,5-b]furan-7-yl acetate
[(3ar,4as,5s,7as,8s,9ar)-5-hydroxy-8-methyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-4a-yl]methyl acetate
[(2s)-2-[2-(tert-butoxy)-5-methoxy-4-methylphenyl]oxiran-2-yl]methyl acetate
(3ar,4s,7ar)-5-[(2s)-5-hydroxypentan-2-yl]-6-methyl-3-methylidene-2-oxo-3a,4,7,7a-tetrahydro-1-benzofuran-4-yl acetate
10-methyl-5-pentyl-13-(prop-1-en-2-yl)-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2(7),3,5,10,12-hexaen-3-ol
(3r,3as,4s,10s,11ar)-3,6,10-trimethyl-2,9-dioxo-3h,3ah,4h,5h,8h,10h,11h,11ah-cyclodeca[b]furan-4-yl acetate
(4s,5s,9as)-4-hydroxy-6,6,9a-trimethyl-3-oxo-1h,4h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-5-yl acetate
(2s,3s,3'ar,6'r)-6'-hydroperoxy-3',3',6'-trimethyl-1',3'a,4',5'-tetrahydro-2h-spiro[furan-3,2'-inden]-2-yl acetate
(3ar,4as,5s,7as,8s,9ar)-4a-(hydroxymethyl)-8-methyl-3-methylidene-2-oxo-octahydro-3ah-azuleno[6,5-b]furan-5-yl acetate
(3s,3as,7r,9s,11as)-7-hydroxy-3,10-dimethyl-6-methylidene-2-oxo-3h,3ah,4h,5h,7h,8h,9h,11ah-cyclodeca[b]furan-9-yl acetate
10'-hydroxy-1',2',5'-trimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-11'-yl acetate
(4r,5s,5as,9as)-4-hydroxy-6,6,9a-trimethyl-1-oxo-3h,4h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-5-yl acetate
1-acetoxy-6α-hydroxy-4αh-1,10-secoeudesma-5(10),11(13)-dien-12,8β-olide
{"Ingredient_id": "HBIN002239","Ingredient_name": "1-acetoxy-6\u03b1-hydroxy-4\u03b1h-1,10-secoeudesma-5(10),11(13)-dien-12,8\u03b2-olide","Alias": "NA","Ingredient_formula": "C17H24O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14126","TCMID_id": "236","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1β-acetoxy-7-drimen-11α-ol-12,11-lactone
{"Ingredient_id": "HBIN002381","Ingredient_name": "1\u03b2-acetoxy-7-drimen-11\u03b1-ol-12,11-lactone","Alias": "NA","Ingredient_formula": "C17H24O5","Ingredient_Smile": "CC(=O)OC1CCC(C2C1(C3C(OC(=O)C3=CC2)O)C)(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "176","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
4-acetoxy-1β,5β-epoxy-10αh-xantha-11(13)-en-12,8β-olide
{"Ingredient_id": "HBIN010159","Ingredient_name": "4-acetoxy-1\u03b2,5\u03b2-epoxy-10\u03b1h-xantha-11(13)-en-12,8\u03b2-olide","Alias": "NA","Ingredient_formula": "C17H24O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "191","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-α-acetyl-4-o-oxobedfordiaicacid
{"Ingredient_id": "HBIN012196","Ingredient_name": "6-\u03b1-acetyl-4-o-oxobedfordiaicacid","Alias": "NA","Ingredient_formula": "C17H24O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "474","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8α-acetoxy-1β-hydroxyeudesm-3-en-5α,6β,7α,11βh-12,6-olide
{"Ingredient_id": "HBIN013617","Ingredient_name": "8\u03b1-acetoxy-1\u03b2-hydroxyeudesm-3-en-5\u03b1,6\u03b2,7\u03b1,11\u03b2h-12,6-olide","Alias": "NA","Ingredient_formula": "C17H24O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "217","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
affinisine
{"Ingredient_id": "HBIN014774","Ingredient_name": "affinisine","Alias": "NA","Ingredient_formula": "C20H24N2O","Ingredient_Smile": "CC=C1CN2C3CC1C(C2CC4=C3N(C5=CC=CC=C45)C)CO","Ingredient_weight": "308.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "669","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101286222","DrugBank_id": "NA"}
Bakkenolide-X
{"Ingredient_id": "HBIN017543","Ingredient_name": "Bakkenolide-X","Alias": "NA","Ingredient_formula": "C17H24O5","Ingredient_Smile": "CC1CCC(C2C1(CC3(C2O)C(=C)COC3=O)C)OC(=O)C","Ingredient_weight": "308.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "35683","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10733601","DrugBank_id": "NA"}